Evidence map›Paper›PMID 21112823›Full record

ArticleStem cell research2011

Nonmitogenic survival-enhancing autocrine factors including cyclophilin A contribute to density-dependent mouse embryonic stem cell growth.

Nikhil Mittal, Joel Voldman

Open access · greenAbstract read
In one paragraph

Article in Stem cell research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Attenuation of extrinsic signaling reveals the importance of matrix remodeling on maintenance of embryonic stem cell self-renewal.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  9. Probing embryonic stem cell autocrine and paracrine signaling using microfluidics.Annual review of analytical chemistry (Palo Alto, Calif.) · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nikhil MittalDepartment of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Joel Voldman
Massachusetts Institute of Technology · US

Funding

Microscale control of stem cell signaling using cell patterning and perfusionR01EB007278 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VOLDMAN, JOEL · 2007 to 2010
$1.3M
NIBIB NIH HHS EB007278NIBIB NIH HHS R01 EB007278
6 · The paper itself

Abstract

An improved understanding of the role of extracellular factors in controlling the embryonic stem cell (ESC) phenotype will aid the development of cell-based therapies. While the role of extracellular factors in controlling the pluripotency and differentiation of embryonic stem cells (ESCs) has been the subject of much investigation, the identity and role of extrinsic factors in modulating ESC growth under conditions supporting self-renewal remain largely unknown. We demonstrate that mouse ESC (mESC) growth is density dependent and that one of the mechanisms underlying this phenomenon is the action of survival-enhancing autocrine factors. Proteomic analysis of proteins secreted by mouse ESCs demonstrates significant levels of cyclophilin A which increases the growth rate of mouse ESCs in a dose-dependent manner. Additionally, inhibition of the cyclophilin A receptor CD147 decreases the growth rate of mESCs. These findings identify cyclophilin A as a novel survival-enhancing autocrine factor in mouse ESC cultures.

Indexed as

Autocrine CommunicationAnimalsCell Culture TechniquesCell CycleCell DifferentiationCell ProliferationCells, CulturedCulture MediaCyclophilin AEmbryonic Stem CellsIntercellular Signaling Peptides and ProteinsMiceCulture MediaCyclophilin AIntercellular Signaling Peptides and Proteins

Identifiers

PMID21112823
PMCPMC3077536
OpenAlexW2085233970

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.